Drugs / Bictegravir / Emtricitabine / Tenofovir Alafenamide
Bictegravir / Emtricitabine / Tenofovir Alafenamide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04585737 Comparator | Oct 2020 → Aug 2023 | HIV infectious disease | Charlotte-Paige Rolle, MD | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bictegravir / Emtricitabine / Tenofovir Alafenamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04585737 ↗ |